The Globe and Mail

Go to the Globe and Mail homepage

Jump to main navigationJump to main content

The Globe and Mail has
updated our Stock Quote Pages
You are about to experience the newly designed Stock Quote Pages format. With the new layout, you'll enjoy a more in-depth look at the companies you're following and pages that are easier to navigate. This Editors' blog post explains why we've made these changes.

 

GlaxoSmithKline PLC

NYSE: GSK
Last

(U.S.) $43.44

Today's change-0.15 -0.34%
Updated July 31 4:03 PM EDT. Delayed by at least 15 minutes.
 

GlaxoSmithKline PLC

NYSE: GSK
Last

(U.S.) $43.44

Today's change-0.15 -0.34%
Updated July 31 4:03 PM EDT. Delayed by at least 15 minutes.

Reversal following new 20-day high

GlaxoSmithKline PLC closed lower Friday, dropping (U.S.)$0.15 or 0.34% to (U.S.)$43.44 after setting a new 20-day high. Over the last five days, shares have gained 4.95%, but are currently unchanged over the last year to date. Shares have underperformed the S&P 500 by 19.16% during the last year.

Key company metrics

  • Open(U.S.) $43.68
  • Previous close(U.S.) $43.59
  • High(U.S.) $43.71
  • Low(U.S.) $43.37
  • Bid / Ask-- / --
  • YTD % change+1.64%
  • Volume4,247,055
  • Average volume (10-day)4,373,840
  • Average volume (1-month)4,184,733
  • Average volume (3-month)4,122,208
  • 52-week range(U.S.) $41.19 to (U.S.) $49.24
  • Beta0.67
  • Trailing P/E6.93×
  • P/E 1 year forward18.56×
  • Forward PEG2.44×
  • Indicated annual dividend(U.S.) $2.49
  • Dividend yield5.73%
  • Trailing EPS(U.S.) $6.27
Updated July 31 4:03 PM EDT. Delayed by at least 15 minutes.

Profit

Net Profit (TTM)
+40.97%

Based on its net profit margin of 40.97%, GlaxoSmithKline PLC is among the more effective companies in its industry at turning revenues into bottom line profit.
Company Books

S&P TSX0.60%Sector:Industry:
  • Income Statement
  • Balance Sheet
  • Cash Flow
Quarter | Annual
Q2/2015Q1/2015Q4/2014Q3/2014
Fiscal Quarter Endvalues in $ millions unless otherwise notedJun 30, 201506/30/2015Mar 31, 201503/31/2015Dec 31, 201412/31/2014Sep 30, 201409/30/2014
Revenue5,8885,6226,1865,646
Total other revenue--------
Total revenue5,8885,6226,1865,646
Gross profit3,9933,7454,2783,894
Total cost of revenue1,8951,8771,9081,752
Total operating expense5,552-4,4375,4954,943
Selling / general / administrative2,1411,9511,9391,795
Research & development731789821742
Depreciation / amortization9131517
Interest expense (income), net operating--------
Unusual expense (income)838-8,990532738
Other operating expenses, total-62-77280-101
Operating income33610,059691703
Interest income (expense), net non-operating--------
Gain (loss) on sale of assets--------
Other--------
Income before tax1529,923531548
Income after tax1158,0381,025385
Income tax, total371,885-494163
Net income1498,0891,033401
Total adjustments to net income--------
Net income before extra. items1498,0891,033401
Minority interest3451816
Equity in affiliates--------
U.S. GAAP adjustment--------
Inc. avail. to common excl. extra. items1498,0891,033401
Inc. avail. to common incl. extra. items1498,0891,033401
Diluted net income1498,0891,033401
Dilution adjustment--------
Diluted weighted average shares4,8744,8204,8114,865
Diluted EPS excluding extraordinary itemsvalue per share0.031.680.210.08
Dividends per sharevalue per share0.190.190.230.19
Diluted normalized EPSvalue per share0.160.170.190.21